| 0 (0%) | 12-26 21:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.11 | 1-year : | 0.12 |
| Resists | First : | 0.09 | Second : | 0.1 |
| Pivot price | 0.08 |
|||
| Supports | First : | 0.07 | Second : | 0.05 |
| MAs | MA(5) : | 0.07  |
MA(20) : | 0.08 |
| MA(100) : | 0.1 |
MA(250) : | 0.28 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 9.6 |
D(3) : | 22.6 |
| RSI | RSI(14): 44.6 |
|||
| 52-week | High : | 3.39 | Low : | 0.05 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BPTH ] has closed above bottom band by 24.0%. Bollinger Bands are 6.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.08 - 0.08 | 0.08 - 0.08 |
| Low: | 0.07 - 0.07 | 0.07 - 0.07 |
| Close: | 0.07 - 0.07 | 0.07 - 0.07 |
Thu, 24 Jul 2025
Maharashtra NEET UG Counselling 2025 begins for MBBS, BDS admissions; check details here - India Today
Tue, 24 Jun 2025
Bio-Path Holdings announces executive resignations and operational pause - Investing.com
Wed, 04 Jun 2025
Roth Capital Lowers Bio-Path (BPTH) PT to $2 Amidst Pipeline Updates, Liquidity Concerns - Insider Monkey
Tue, 03 Jun 2025
Bio-Path Holdings, Inc. Provides Update on Clinical Development Progress and Pipeline Advances - Nasdaq
Tue, 18 Feb 2025
Bio-Path Holdings to be delisted from Nasdaq - Investing.com
Sat, 17 Feb 2024
When Can We Expect A Profit From Bio-Path Holdings, Inc. (NASDAQ:BPTH)? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 8 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 5.2 (%) |
| Shares Short | 79 (K) |
| Shares Short P.Month | 250 (K) |
| EPS | -0.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.87 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -278.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.57 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.12 |
| PEG Ratio | 0 |
| Price to Book value | -0.09 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|